Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1-2
|
pubmed:dateCreated |
1996-10-17
|
pubmed:abstractText |
We investigated the existence of antibodies in sera of Alzheimer's disease patients which immunoreact with specific antigens from crude human brain extracts. We found that 49% of patients, per only 5% of control subjects, had increased levels of antibodies to a 240 kDa protein. On the basis of immunological criteria and internal amino acid sequencing, this antigen was identified as brain spectrin, a cytoskeletal protein which appears to be implicated in synaptic plasticity. Our data raises the possibility that anti-spectrin antibodies could be implicated in Alzheimer's disease pathogenesis.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0165-5728
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
68
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
39-44
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8784258-Adult,
pubmed-meshheading:8784258-Age Factors,
pubmed-meshheading:8784258-Aged,
pubmed-meshheading:8784258-Alzheimer Disease,
pubmed-meshheading:8784258-Amino Acid Sequence,
pubmed-meshheading:8784258-Antibody Specificity,
pubmed-meshheading:8784258-Blotting, Western,
pubmed-meshheading:8784258-Brain Chemistry,
pubmed-meshheading:8784258-Cell Extracts,
pubmed-meshheading:8784258-Cytoskeleton,
pubmed-meshheading:8784258-Humans,
pubmed-meshheading:8784258-Middle Aged,
pubmed-meshheading:8784258-Molecular Sequence Data,
pubmed-meshheading:8784258-Spectrin
|
pubmed:year |
1996
|
pubmed:articleTitle |
Antibodies to human brain spectrin in Alzheimer's disease.
|
pubmed:affiliation |
Centro de Biología Molecular Severo Ochod Universidad Autónoma de Madrid, Cantoblanco, Spain. jvazquez@mvax.cbm.uam.es
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|